BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35546636)

  • 1. Recurrent YAP1::MAML2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
    Perret R; Tallegas M; Velasco V; Soubeyran I; Coindre JM; Azmani R; Baud J; Bacle G; De Pinieux G; Le Loarer F
    Mod Pathol; 2022 Oct; 35(10):1398-1404. PubMed ID: 35546636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
    Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity.
    Dermawan JK; DiNapoli SE; Sukhadia P; Mullaney KA; Gladdy R; Healey JH; Agaimy A; Cleven AH; Suurmeijer AJH; Dickson BC; Antonescu CR
    Genes Chromosomes Cancer; 2023 Apr; 62(4):191-201. PubMed ID: 36344258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-sequencing of myxoinflammatory fibroblastic sarcomas reveals a novel SND1::BRAF fusion and 3 different molecular aberrations with the potential to upregulate the TEAD1 gene including SEC23IP::VGLL3 and TEAD1::MRTFB gene fusions.
    Klubíčková N; Agaimy A; Hájková V; Ptáková N; Grossmann P; Šteiner P; Michal M; Michal M
    Virchows Arch; 2022 Oct; 481(4):613-620. PubMed ID: 35776191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytopathology of myxoinflammatory fibroblastic sarcoma: a series of eight cases and review of the literature.
    Wangsiricharoen S; Ali SZ; Wakely PE
    J Am Soc Cytopathol; 2021; 10(3):310-320. PubMed ID: 33431307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myxoinflammatory Fibroblastic Sarcoma.
    Wu H; Laskin WB
    Surg Pathol Clin; 2024 Mar; 17(1):83-96. PubMed ID: 38278610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myxoinflammatory fibroblastic sarcoma: a clinicopathologic study of 6 cases with review of literature].
    Xiang H; Shi XL; Li QX; Zhang W; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):94-8. PubMed ID: 21426804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
    Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases.
    Michal M; Kazakov DV; Hadravský L; Kinkor Z; Kuroda N; Michal M
    Ann Diagn Pathol; 2015 Jun; 19(3):157-63. PubMed ID: 25886867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
    Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
    Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxoinflammatory fibroblastic sarcoma: an immunohistochemical and molecular genetic study of 73 cases.
    Suster D; Michal M; Huang H; Ronen S; Springborn S; Debiec-Rychter M; Billings SD; Goldblum JR; Rubin BP; Michal M; Suster S; Mackinnon AC
    Mod Pathol; 2020 Dec; 33(12):2520-2533. PubMed ID: 32514165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent Advances in the Diagnosis, Pathogenesis, and Management of Myxoinflammatory Fibroblastic Sarcoma.
    Nishio J; Nakayama S; Aoki M
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep sequencing of myxoinflammatory fibroblastic sarcoma.
    Arbajian E; Hofvander J; Magnusson L; Mertens F
    Genes Chromosomes Cancer; 2020 May; 59(5):309-317. PubMed ID: 31898851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
    Antonescu CR; Dickson BC; Sung YS; Zhang L; Suurmeijer AJH; Stenzinger A; Mechtersheimer G; Fletcher CDM
    Am J Surg Pathol; 2020 Dec; 44(12):1677-1684. PubMed ID: 32991341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
    Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
    Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consistent t(1;10) with rearrangements of TGFBR3 and MGEA5 in both myxoinflammatory fibroblastic sarcoma and hemosiderotic fibrolipomatous tumor.
    Antonescu CR; Zhang L; Nielsen GP; Rosenberg AE; Dal Cin P; Fletcher CD
    Genes Chromosomes Cancer; 2011 Oct; 50(10):757-64. PubMed ID: 21717526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent BRAF Gene Fusions in a Subset of Pediatric Spindle Cell Sarcomas: Expanding the Genetic Spectrum of Tumors With Overlapping Features With Infantile Fibrosarcoma.
    Kao YC; Fletcher CDM; Alaggio R; Wexler L; Zhang L; Sung YS; Orhan D; Chang WC; Swanson D; Dickson BC; Antonescu CR
    Am J Surg Pathol; 2018 Jan; 42(1):28-38. PubMed ID: 28877062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxoinflammatory fibroblastic sarcoma in children and adolescents: clinicopathologic aspects of a rare neoplasm.
    Weiss VL; Antonescu CR; Alaggio R; Cates JM; Gaskin D; Stefanovici C; Coffin CM
    Pediatr Dev Pathol; 2013; 16(6):425-31. PubMed ID: 23919754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myxoinflammatory fibroblastic sarcoma: a clinicopathologic analysis of 104 cases, with emphasis on predictors of outcome.
    Laskin WB; Fetsch JF; Miettinen M
    Am J Surg Pathol; 2014 Jan; 38(1):1-12. PubMed ID: 24121178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.